Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
$2.41
-2.0%		$1.73
$1.17
▼
$2.58
$641.45M2.073.34 million shs2.41 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,257.26
+1.0%		$1,180.14
$694.23
▼
$1,292.65
$1.18T0.512.83 million shs2.50 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
0.00%+12.09%+58.55%+41.76%+39.31%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.00%+6.35%+6.07%+17.88%+78.40%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
$2.41
-2.0%		$1.73
$1.17
▼
$2.58
$641.45M2.073.34 million shs2.41 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,257.26
+1.0%		$1,180.14
$694.23
▼
$1,292.65
$1.18T0.512.83 million shs2.50 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
0.00%+12.09%+58.55%+41.76%+39.31%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.00%+6.35%+6.07%+17.88%+78.40%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2.88
Moderate Buy$10.00314.94% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,292.182.78% Upside

Current Analyst Ratings Breakdown

Latest LLY and AUTL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/11/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B) ➝ Buy (B-)
8/7/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$1,376.00
8/7/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$1,370.00 ➝ $1,376.00
8/6/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$1,419.00
8/6/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$1,280.00 ➝ $1,330.00
8/6/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$1,400.00
8/6/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$1,350.00 ➝ $1,410.00
8/3/2026
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
7/31/2026
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/15/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$1,500.00 ➝ $1,600.00
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
$75.39M8.51N/AN/A$0.28 per share8.61
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B18.16$25.18 per share49.94$35.99 per share34.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
-$287.53M-$1.06N/AN/AN/A-238.66%-178.66%-49.34%10/29/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$29.8042.1927.411.4833.53%97.83%23.23%10/29/2026 (Estimated)

Latest LLY and AUTL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
-$0.21-$0.15+$0.06-$0.15$38.56 million$45.69 million
8/5/2026Q2 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.40$8.38+$1.98$7.94$20.82 billion$22.97 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.55%+15.18%23.22%11 Years

Latest LLY and AUTL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.59%8/14/20268/14/20269/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
1.04
4.89
4.40
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.41
1.35
1.00

Institutional Ownership

CompanyInstitutional Ownership
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
72.83%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%

Insider Ownership

CompanyInsider Ownership
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
25.70%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
330266.16 million197.76 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.36 million940.04 millionOptionable

Recent News About These Companies

Pursue Wealth Partners LLC Sells 824 Shares of Eli Lilly and Company $LLY
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pursue-wealth-partners-llc-sells-824-shares-of-eli-lilly-and-company-lly-2026-08-23/
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
 |  fool.comhttps://www.fool.com/investing/2026/08/23/billionaire-ken-griffin-just-loaded-up-on-eli-lill/?source=marketbeat&utm_source=marketbeat&utm_medium=feed&utm_campaign=article&referring_guid=57a98fb3-e939-43ef-bd1f-8f226d1049fb
Trust Co. of Vermont Acquires New Position in Eli Lilly and Company $LLY
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-trust-co-of-vermont-acquires-new-position-in-eli-lilly-and-company-lly-2026-08-23/
Eli Lilly and Company $LLY Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-eli-lilly-and-company-lly-shares-bought-by-mitsubishi-ufj-asset-management-co-ltd-2026-08-23/
Eli Lilly and Company $LLY Shares Bought by Simplicity Wealth LLC
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-eli-lilly-and-company-lly-shares-bought-by-simplicity-wealth-llc-2026-08-23/
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
 |  fool.comhttps://www.fool.com/investing/2026/08/23/billionaire-ken-griffin-just-loaded-up-on-eli-lill/
Deutsche Bank AG Trims Stock Position in Eli Lilly and Company $LLY
August 23 at 3:36 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-trims-stock-position-in-eli-lilly-and-company-lly-2026-08-23/
Commerzbank Aktiengesellschaft FI Raises Position in Eli Lilly and Company $LLY
August 23 at 3:36 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-commerzbank-aktiengesellschaft-fi-raises-position-in-eli-lilly-and-company-lly-2026-08-23/
Eli Lilly and Company $LLY Shares Bought by BlackRock Inc.
August 23 at 3:27 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-eli-lilly-and-company-lly-shares-bought-by-blackrock-inc-2026-08-23/
Eli Lilly and Company (NYSE:LLY) Lowered to "Buy" Rating by Wall Street Zen
August 23 at 1:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30977106
Eli Lilly and Company (NYSE:LLY) Rating Lowered to Buy at Wall Street Zen
August 23 at 1:06 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/eli-lilly-and-company-nyselly-rating-lowered-to-buy-at-wall-street-zen-2026-08-23/
Promising Pharmaceutical Stocks To Keep An Eye On - August 22nd
August 22 at 2:00 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/promising-pharmaceutical-stocks-to-keep-an-eye-on-august-22nd-2026-08-22/
Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk
August 22 at 11:30 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4939364-eli-lilly-shaking-off-competition-from-dethroned-novo-nordisk?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk
August 22 at 11:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4939364-eli-lilly-shaking-off-competition-from-dethroned-novo-nordisk
Illustration of a vial with an upward stock price chart and DNA double helix against a city skyline, symbolizing biotech growth.
2 Biotech Stocks Shaping Up for Major Breakouts
...
August 22 at 11:00 AM  |  marketbeat.comhttps://www.marketbeat.com/articles/2-biotech-stocks-shaping-up-for-major-breakouts/
Eli Lilly (LLY) Is Up 6.4% After UK Clears Foundayo and GLP‑1 Portfolio Advances - What's Changed
August 22 at 9:48 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/eli-lilly-lly-6-4-041817693.html
Will Eli Lilly’s Global Vault CRM Deal and Leadership Shift Change Veeva Systems’ (VEEV) Narrative?
August 22 at 9:48 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/eli-lilly-global-vault-crm-080851754.html
Trivium Point Advisory LLC Purchases 9,975 Shares of Eli Lilly and Company $LLY
August 22 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-trivium-point-advisory-llc-purchases-9975-shares-of-eli-lilly-and-company-lly-2026-08-22/
Eli Lilly and Company $LLY is Nippon Life Global Investors Americas Inc.'s 7th Largest Position
August 22 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-eli-lilly-and-company-lly-is-nippon-life-global-investors-americas-incs-7th-largest-position-2026-08-22/
Eli Lilly and Company $LLY Stock Holdings Boosted by J.Safra Asset Management Corp
August 22 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-eli-lilly-and-company-lly-stock-holdings-boosted-by-jsafra-asset-management-corp-2026-08-22/
Horizon Investment Services LLC Boosts Stake in Eli Lilly and Company $LLY
August 22 at 4:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-horizon-investment-services-llc-boosts-stake-in-eli-lilly-and-company-lly-2026-08-22/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
Illustration of a vial with an upward stock price chart and DNA double helix against a city skyline, symbolizing biotech growth.
2 Biotech Stocks Shaping Up for Major Breakouts
By Ryan Hasson | August 22, 2026
Autolus Therapeutics stock logo

Autolus Therapeutics NASDAQ:AUTL

$2.41 -0.05 (-2.03%)
As of 08/21/2026 04:00 PM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. Autolus Therapeutics plc was incorporated in 2014 and is headquartered in London, the United Kingdom.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,257.26 +12.86 (+1.03%)
As of 08/21/2026 03:58 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas